Alpha-0261 Tablets for Moderate-to-Severe Ulcerative Colitis
Alpha-0261 Tablets for Moderate-to-Severe Ulcerative Colitis
Not yet recruiting · NCT07744646 · Registry updated 2026-08-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Alpha-0261 Tablets for Moderate-to-Severe Ulcerative Colitis | Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Not yet recruiting | Phase 1 | 2026-08-04 | NCT07744646 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AlphaMol Science Ltd. (Shanghai) | 2 |
| The First Affiliated Hospital of Anhui Medical University | 85 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital of Anhui Medical University | Hefei | China | 23 |